CCND1 and cancer: Endogenous cyclin D1 mRNA expression level without treatment was higher in HSC-3 cells and MG-63 cells than in other cancer cells (Hela cells) and HEK293 cells (Figure 5A), suggesting that efficiency of sgRNA targeting of cyclin D1 may depend upon the endogenous cyclin D1 expression levels.